Filing Flows › Zymeworks (ZYME) › Guidance history
Zymeworks (ZYME) guidance history: what it guided and what it reported
Zymeworks gave guidance in 4 earnings releases on file since Jan 12, 2026. Its releases raised guidance once and lowered it 0 times.
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $190–$176M (Nov 9, 2026) | — | to be reported | — |
The latest quarter
Zymeworks, Q3 2026: revenue $256M (+829% year over year), operating margin 69.2%, net earnings $174M, operating cash flow −$24.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Zymeworks beat its guidance?
Zymeworks gave guidance in 4 earnings releases on file since Jan 12, 2026. Its releases raised guidance once and lowered it 0 times.
How often does Zymeworks raise guidance?
Its earnings releases raised guidance once and lowered it 0 times since Jan 12, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.